COMPANY
Nilogen Oncosystems
Timeline
- Trial start Early phase 1: Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03371992 | Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC | Early phase 1 | Unknown status (ClinicalTrials.gov) | Mar 9, 2018 | 2020-12 (estimated) |